Management are being proactive by locking down the action plan...

Management are being proactive by locking down the action plan with the FDA.

They need that element sorted to have clarity. Then another indication can proceed.

Then management can perhaps give clarity on the additional less than 10 indications, having sniffed the wind.

Then they can articulate planning for phase 3’s and lock the plans for those FDA wise.

Then when that picture is painted, we will see IF NEU require having to build phase 3 program/s and the competence crew to drive it.

But, that above process may be enough to flush out any suitors that are lurking.

If not, develop the unnamed indications, and implement the Phase 3’s and/or license out all/or some of the pipeline.

Licencing ala Acadia, but better terms could make US$1Bill ++++++++ in income to NEU shareholders annually.
10+ indications possibly.

The clock is ticking. The ticking is not going to detonate a bomb. Just a direction of certainty.

.